|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-10-26
|
|
pubmed:abstractText |
To evaluate the safety, maximum tolerated dose (MTD), pharmacokinetics (PK), and pharmacodynamics (PD) of the acetyl-selective anticholinesterase, phenserine tartrate, in healthy elderly subjects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1567-2050
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
483-92
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16248851-Acetylcholinesterase,
pubmed-meshheading:16248851-Aged,
pubmed-meshheading:16248851-Area Under Curve,
pubmed-meshheading:16248851-Cholinesterase Inhibitors,
pubmed-meshheading:16248851-Erythrocytes,
pubmed-meshheading:16248851-Female,
pubmed-meshheading:16248851-Humans,
pubmed-meshheading:16248851-Male,
pubmed-meshheading:16248851-Maximum Tolerated Dose,
pubmed-meshheading:16248851-Middle Aged,
pubmed-meshheading:16248851-Physostigmine
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects.
|
|
pubmed:affiliation |
Drug Design & Development Section, Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224 USA. Greign@grc.nia.nih.gov
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
